Here's a second chance to invest in companies with viable growth potential.
These health care stocks have been growing by double digits. Should you buy?
Why Gilead and Biogen are the best ways to play the biotech meltdown.
Are biotechs to blame for the recent downturn in the S&P 500?
Health-care and high-growth names continue to stumble as a sell-off continues in the stock market today.
Asia tech stocks fall into the red
The 3 worst stocks in the stock market today all hail from the health care sector
Amgen, Biogen Idec, Celgene, Gilead Sciences, Regeneron Pharmaceuticals, and Alexion Pharmaceuticals make up 77% of the increase in the biotech sector over the past three years.
Biogen's Alprolix is now the most convenient hemophilia B treatment available, but competition is on the way.See More Articles...